On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
We recently published a list of 10 Best Big-Name Stocks to Buy Right ... selling on individual US-listed stocks […] A Phase 3 ...
In the first half of 2024, AstraZeneca reported sales that grew more than 10% year over year for 21 different drugs. With ...
Zacks.com on MSN3d
AZN Gets FDA Nod for Fasenra Label Expansion in Rare DiseaseThe FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...
Zacks.com on MSN1d
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ DrugsThis week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...
Health and Me on MSN5d
GST Slashed On Three Cancer Drug: Here's How It Will Affect PatientsThe recent GST cut on cancer drugs could mean significant cost reductions for cancer treatment in India. Read to know how it ...
More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet. The new study by the Global Research ...
Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...
Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
The threshold between one season and another, between one moment and the next, between one way of being and the next one: ...
These are still high on the list of AZ’s core focus today ... to have paid off – between 2005 and 2010 AstraZeneca‘s success rates for taking drugs from candidate nomination to phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback